Cargando…
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
D-Serine is a potent co-agonist at the NMDA glutamate receptor and has been the object of many preclinical studies to ascertain the nature of its metabolism, its regional and cellular distribution in the brain, its physiological functions and its possible clinical relevance. The enzymes involved in...
Autores principales: | MacKay, Mary-Anne B., Kravtsenyuk, Maryana, Thomas, Rejish, Mitchell, Nicholas D., Dursun, Serdar M., Baker, Glen B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372501/ https://www.ncbi.nlm.nih.gov/pubmed/30787885 http://dx.doi.org/10.3389/fpsyt.2019.00025 |
Ejemplares similares
-
Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics
por: MacKay, Mary-Anne B., et al.
Publicado: (2018) -
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
por: Matveychuk, Dmitriy, et al.
Publicado: (2020) -
An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia
por: Orzylowski, Magdalena, et al.
Publicado: (2021) -
Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
por: Tang, Yiguo, et al.
Publicado: (2021) -
Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia
por: Hons, Jaromir, et al.
Publicado: (2021)